# ORO Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/oro-health

- Industry: Software
- Headquarters: Montreal, Canada
- Website: www.orohealth.me
- Latest round: Seed (Aug 11, 2021)
- Investors on record: 3

## About

Based in Canada, ORO Health operates as a virtual healthcare provider specializing in asynchronous telemedicine solutions that improve patient care and streamline workflows for healthcare professionals.Founded in 2018 in Montreal, Canada, ORO Health delivers telemedicine solutions, effectively addressing healthcare accessibility. The co-founders, Emilie Bourgeault, Jean-Philippe Doré, and Marc-Andre Faad, have a background in healthcare technology. The firm has completed 2 deals, with the most recent on August 11, 2021.Oro Health specializes in asynchronous telemedicine solutions tailored for dermatologists and specialists seeking to enhance patient care while optimizing their workflow. The core product offering is the Oro DermSmart AI, an integrated diagnostic and treatment recommendation tool specifically designed for minor skin conditions. This artificial intelligence-driven platform aids in pre-triaging patients, allowing dermatologists to focus on more complex cases while providing patients with timely treatment recommendations without necessitating an in-person consultation. Oro Health's solutions are primarily directed at healthcare professionals in Canada, addressing the critical need for efficient dermatological care, particularly in underserved areas outside major urban centers. The platform is accessible via various devices, enhancing usability for both patients and clinicians, and supports features such as prescription tools, laboratory requests, and direct payment processing.Oro Health's revenue model is structured around subscription services for healthcare professionals who integrate their telemedicine solutions into their practices. Dermatologists and specialists pay for access to the Oro DermSmart AI platform, which streamlines patient interactions and simplifies administrative tasks. Client transactions typically involve subscription fees that cover software usage, maintenance, and ongoing updates to the AI technology. The company focuses on building partnerships with medical clinics and independent practitioners, facilitating direct-to-consumer accessibility for patients seeking dermatological advice and treatment recommendations. These transactional structures are designed to maximize efficiency and satisfaction among users, ensuring that both practitioners and patients benefit from the seamless integration of Oro Health’s technology into everyday healthcare practices.In August 2021, ORO Health raised a total of USD 3 million in equity and debt funding from investors including Desjardins Capital, MCI Onehealth Technologies, Inc., and TGIC2. This funding will be utilized to accelerate the development of its platform and business model. ORO Health plans to introduce new features and enhancements to the Oro DermSmart AI platform while expanding its reach to additional markets in Canada, specifically targeting underserved regions by the end of 2023.

## Funding rounds

- Seed, Aug 11, 2021 — Desjardins Capital, Healwell AI Inc., TGIC2

## Investors

- Desjardins Capital (https://capitalatlas.ai/funds/desjardins-capital) — Seed
- Healwell AI Inc. — Seed
- TGIC2 — Seed